Literature DB >> 22669079

Is the colposcopically directed punch biopsy a reliable diagnostic test in women with minor cytological lesions?

Esther L Moss1, Paula Hadden, Gill Douce, Peter W Jones, Marc Arbyn, Charles W E Redman.   

Abstract

OBJECTIVE: The study aimed to determine the accuracy of the colposcopy-directed punch biopsy (punch) to detect or exclude high-grade cervical intraepithelial neoplasia (CIN 2 or 3) in women with atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LSIL) cytological result and minor colposcopic findings.
MATERIALS AND METHODS: In a diagnostic test accuracy study, women with ASCUS or LSIL cytological result and minor colposcopic changes had a single colposcopy-targeted punch biopsy was performed immediately followed by a loop electrocautery excision procedure (LEEP) biopsy. The trial was powered to detect a level of κ for a dichotomous outcome of 0.4 (i.e., fair-to-moderate agreement), with a two-sided significance level of 5% and a power of 90%. Accuracy parameters were computed using a cutoff for positive punch biopsy result of CIN 1+ and CIN 2+ for an outcome of CIN 2+ and CIN 3+ assessed in the LEEP specimen.
RESULTS: Sixty-eight punch biopsy/LEEP-paired samples were analyzed. Of the 8 CIN 3 lesions, 6 and 4 were detected at cutoff CIN 1+ and CIN 2+, respectively (sensitivity, 50% and 75%). The corresponding specificities were 65% (39/60) and 97% (58/60). The punch biopsies identified only 14 (67%) or 6 (20%) of the 21 CIN 2+ lesions at cutoff CIN 1+ or CIN 2+, respectively. Of the punch biopsies, 31 (45.6%) accurately detected the severity of cervical abnormality.
CONCLUSIONS: A single colposcopically directed punch biopsy appears to be insufficient to exclude underlying CIN 2 or 3.

Entities:  

Mesh:

Year:  2012        PMID: 22669079     DOI: 10.1097/LGT.0b013e318250acf3

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN: 1089-2591            Impact factor:   1.925


  6 in total

1.  Accuracy of Colposcopically Directed Biopsy: Results from an Online Quality Assurance Programme for Colposcopy in a Population-Based Cervical Screening Setting in Italy.

Authors:  Mario Sideri; Paola Garutti; Silvano Costa; Paolo Cristiani; Patrizia Schincaglia; Priscilla Sassoli de Bianchi; Carlo Naldoni; Lauro Bucchi
Journal:  Biomed Res Int       Date:  2015-06-09       Impact factor: 3.411

2.  Diagnostic value of the 2011 International Federation for Cervical Pathology and Colposcopy Terminology in predicting cervical lesions.

Authors:  Aiping Fan; Chen Wang; Liqin Zhang; Ye Yan; Cha Han; Fengxia Xue
Journal:  Oncotarget       Date:  2018-01-08

3.  Can biopsies be omitted after normal colposcopy in women referred with low-grade cervical cytology? A prospective cohort study.

Authors:  Mette Mindedahl Jespersen; Berit Bargum Booth; Lone Kjeld Petersen
Journal:  BMC Womens Health       Date:  2021-11-19       Impact factor: 2.809

4.  The concordance between colposcopic biopsy and loop electrosurgical excision procedures in patients with known smear cytology and human papillomavirus results.

Authors:  Sener Gezer; Sumeyye Kanbay Ozturk; Sibel Balci; Izzet Yucesoy
Journal:  North Clin Istanb       Date:  2021-12-31

5.  Discrepancy between Cytology and Histology in Cervical Cancer Screening: a Multicenter Retrospective Study (KGOG 1040).

Authors:  Yung Taek Ouh; Ji Jeong Park; Minjoo Kang; Miseon Kim; Jae Yun Song; So Jin Shin; Seung Hyuk Shim; Heon Jong Yoo; Maria Lee; Sung Jong Lee; Whan Shin; Gun Oh Chong; Min Chul Choi; Chel Hun Choi; Kyung Jin Min
Journal:  J Korean Med Sci       Date:  2021-06-21       Impact factor: 2.153

6.  A prospective randomized study on limits of colposcopy and histology: the skill of colposcopist and colposcopy-guided biopsy in diagnosis of cervical intraepithelial lesions.

Authors:  Giuseppe Bifulco; Nicoletta De Rosa; Giada Lavitola; Roberto Piccoli; Alessandra Bertrando; Valentina Natella; Costantino Di Carlo; Luigi Insabato; Carmine Nappi
Journal:  Infect Agent Cancer       Date:  2015-11-19       Impact factor: 2.965

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.